# Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer

> **NCT00251355** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 40 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** 5-Fluorouracil
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00251355
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 2007-06
- **Final completion:** 2008-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-12-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251355, "Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00251355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*